BCPC - CIK 0000009326
The table below shows BALCHEM CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $216.56M | $182.00M | $183.76M | $138.54M | $160.51M | $150.49M |
| Capital expenditure | - | - | - | $49.09M | $36.14M | $32.08M |
| Investing cash flow | -$43.89M | -$59.74M | -$34.81M | -$416.01M | -$35.30M | -$34.59M |
| Dividends paid | $28.29M | $25.58M | $22.87M | $20.71M | $18.72M |
BALCHEM CORP reported operating cash flow of $216.56M for fiscal year 2025. That is up 19.0% from $182.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $107.61M (FY 2016) to $216.56M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $16.70M |
| Stock buybacks | $107.64M | $5.68M | $4.47M | $35.42M | $35.24M | $13.46M |
| Financing cash flow | -$152.81M | -$133.81M | -$153.32M | $246.68M | -$102.18M | -$101.16M |